English Abstract
Journal Article
Review
Add like
Add dislike
Add to saved papers

[The position of drospirenone in premenstrual syndrome teratment].

Ceská Gynekologie 2006 January
OBJECTIVE: To evaluate influence of hormonal contraceptive drospirenone on premenstrual syndrome (PMS).

DESIGN: Overall summary of literature. AUTHOR AFFILIATION: ADC Sanatorium, Praha.

METHODS: Review of scientific studies and publications.

CONCLUSIONS: The author submitted current opinions on premenstrual syndrome, its classification, and treatment. The role of renin--aldosterone system in the genesis of PMS was described. Basic pharmacological characteristics of the remedy containing in one pill 30 mg of Ethinyl Estradiol (EE) and 3 mg of drospirenone are presented. Its therapeutic effects on somatic and psychological PMS symptoms are discussed.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app